Key clinical point: A group of hematology specialists provided consensus statements on the evaluation of bleeding in patients with acquired hemophilia.

Major finding: If expert hematologist consultation is not available, and the bleeding event is life‐threatening, the emergency physician should initiate treatment in accordance with local or national recommendations.

Study details: Consensus recommendations provided by 36 global experts in acquired hemophilia.

Disclosures: The manuscript was funded by Novo Nordisk AG. The authors reported having financial affiliations with Novo Nordisk and several other companies.